NEAT1 and cancer: This oncogenic role of NEAT1 in cancers suggests that it may be a promising biomarker and also a candidate therapeutic target pending the completion of further studies into the underlying mechanisms (Carpenter et al., 2013; Ii et al., 2014; Liu et al., 2015).